Clinical Trials in Washington D.C.

Washington D.C. is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Washington D.C. and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 131 actively recruiting studies with Washington D.C. sites out of 131 registered in total. The busiest research areas in Washington D.C. are Breast Cancer, Carcinoma, Non-Small-Cell Lung, Sickle Cell Disease. Leading sponsors running trials in the state include Georgetown University, National Cancer Institute (NCI), AstraZeneca. By stage, Washington D.C. trials break down as Phase 1 (14), Phase 2 (34), Phase 3 (43), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials

131

Recruiting Now

131

← Back to US Map

Top Conditions in Washington D.C.

Breast Cancer (4)Carcinoma, Non-Small-Cell Lung (3)Sickle Cell Disease (3)Hypertension (2)Stage III Pancreatic Cancer AJCC v8 (2)Chronic Kidney Diseases (2)Opioid Use Disorder (2)Hormone Receptor-positive Breast Cancer (2)Amyotrophic Lateral Sclerosis (2)Obesity (2)Acute Myeloid Leukemia (2)Diffuse Intrinsic Pontine Glioma (2)

Frequently Asked Questions — Clinical Trials in Washington D.C.

How many clinical trials are currently recruiting in Washington D.C.?

ClinicalMetric currently tracks 131 actively recruiting clinical trials with at least one location in Washington D.C.. The total number of registered studies—including active but not currently enrolling trials—is 131. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.

What types of clinical trials are available in Washington D.C.?

Washington D.C. hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Carcinoma, Non-Small-Cell Lung, Sickle Cell Disease, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Washington D.C. serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.

How do I join a clinical trial near me in Washington D.C.?

To join a clinical trial in Washington D.C., browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Washington D.C. maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Clinical Trials in Washington D.C.

Frequently Asked Questions — Clinical Trials in Washington D.C.

Recruiting Trials in Washington D.C.